Clinical Trials Directory

Trials / Completed

CompletedNCT04137666

NRS 2002: Nutritional Screen in Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
Sociedad de Lucha Contra el Cáncer del Ecuador · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Diagnosing the nutritional status of cancer patients is extremely important. An appropriate nutritional status supports a better tolerance to the treatment. A working protocol is essential to start with Nutritional Screening. If it is detected Malnutrition Risk or Malnutrition, diet counseling, and the specific therapeutic for each patient must be provided. This descriptive study will serve three aims: * Register in the cancer patient's electronic medical record their nutritional status at the admission and when the patient is discharged. * Determine the percentage of malnourished patients or in the risk of malnutrition who are admitted to hospitalization. * Recognize the number of patients that required specialized nutritional care. The purpose of this study is to determine if 30% of the patients admitted to the headquarters of SOLCA in Guayaquil from the Ecuadorian Cancer Society are at malnutrition risk or with any specific malnutrition level.

Detailed description

A prospective, descriptive, non-interventional study that will be performed from July 1st to October 4th of 2019 in all hospitalized patients of the Internal Medicine Service from SOLCA in Guayaquil from the Ecuadorian Cancer Society. Statistical analysis: Central tendency measures. The results will be presented with tables and graphs. Two weeks before the start of the study, the training of the personnel that will intervene in the screening of the participants will be carried out and will have a flow chart of actions to follow according to the status of patients.

Conditions

Timeline

Start date
2019-06-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2019-10-24
Last updated
2019-10-24

Locations

1 site across 1 country: Ecuador

Source: ClinicalTrials.gov record NCT04137666. Inclusion in this directory is not an endorsement.